| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Gastrointestinal stromal cell tumor GISTKidney (Neoplasm)SunitinibMenetrier s diseaseArthritis (rheumatoid)Bartonella henselaeCandida (BASKET)CoccidioidomycosisOvary (Neoplasia)HistoplasmosisTestis (Neoplasia)Lymphoma (Hodgkin)Calcium (Hypercalciemia)CryptococcosisLangerhans cell histiocytosisLiver (Diseases)LepraLung (Neoplasm)Lymphoma (BASKET)Crohn s diseaseMycobacterium aviumOsteoarthritisSarcoidosisTuberculosisWegener s granulomatosisPneumocystis carinii Pneumocystis jiroviciiParacoccoidomycosisBacillus calmette guerinPseudolymphoma (Lymphomatoid granulomatosis)Lipoid pneumoniaLung (Toxicology)PolymyositisSiliconeSlack skin diseaseFat necrosis subcutaneous of the newbornPseudolymphoma (Plasma cell granuloma)Testis (Neoplasia Seminoma)Carney s complexNervous system (Neoplasia Paraganglioma)Neoplasia (Inherited)ImatinibChanges in terminology| 1 | 1969 | Sarcoma of the stomach: a review of 39 cases. | 
| + | - | nl | South Med J 62(9):1064-71 (1969) |
| 2 | 2008 | Treatment of gastrointestinal stromal tumor: focus on imatinib mesylate. | 
| + | - | nl | Ther Clin Risk Manag 4(1):149-62 (2008) |
| 3 | 2007 | Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST). | 
| + | - | nl | Ther Clin Risk Manag 3(2):341-8 (2007) |
| 4 | 2005 | Imatinib for the treatment of patients with unresectable and/or metastatic gastrointestinal stromal tumours: systematic review and economic evaluation. | 
| + | - | nl | Health Technol Assess 9(25):1-142 (2005) |
| 5 | 2006 | Gastrointestinal stromal tumours: consensus statement on diagnosis and treatment. | 
| + | - | nl | Can J Gastroenterol 20(3):157-63 (2006) |
| 6 | 2009 | Gastrointestinal stromal tumours: outcomes of surgical management and analysis of prognostic variables. | 
| + | - | nl | Can J Surg 52(1):31-8 (2009) |
| 7 | 1998 | Gastrointestinal stromal tumours: an update. | 
| + | - | nl | Sarcoma 2(3-4):133-41 (1998) |
| 8 | 2006 | Clinical presentation and treatment of gastrointestinal stromal tumors. | 
| + | - | nl | Tumori 92(4):279-84 (2006) |
| 9 | 2008 | Gastrointestinal stromal tumors: ESMO clinical recommendations for diagnosis, treatment and follow-up. | 
| + | - | nl | Ann Oncol 19 Suppl 2(-):ii35-8 (2008) |
| 10 | 2007 | Advances in the treatment of gastrointestinal stromal tumours. | 
| + | - | nl | Ann Oncol 18 Suppl 10(-):x20-4 (2007) |
| 11 | 2007 | Gastrointestinal stromal tumors (GISTs): focus on histopathological diagnosis and biomolecular features. | 
| + | - | nl | Ann Oncol 18 Suppl 6(-):vi136-40 (2007) |
| 12 | 2006 | Gastrointestinal stromal tumor (GIST). | 
| + | - | nl | Ann Oncol 17 Suppl 10(-):x280-6 (2006) |
| 13 | 2005 | Consensus meeting for the management of gastrointestinal stromal tumors. Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO. | 
| + | - | nl | Ann Oncol 16(4):566-78 (2005) |
| 14 | 2008 | Genetic aberrations of gastrointestinal stromal tumors. | 
| + | - | nl | Cancer 113(7):1532-43 (2008) |
| 15 | 2005 | Gastrointestinal stromal tumor: 5 years later. | 
| + | - | nl | Cancer 104(9):1781-8 (2005) |
| 16 | 2005 | Update on the biology and therapy of gastrointestinal stromal tumors. | 
| + | - | nl | Cancer Control 12(1):44-56 (2005) |
| 17 | 2001 | Gastrointestinal stromal tumors. | 
| + | - | nl | Cancer Control 8(3):252-61 (2001) |
| 18 | 2007 | Approval summary: sunitinib for the treatment of imatinib refractory or intolerant gastrointestinal stromal tumors and advanced renal cell carcinoma. | 
| + | - | nl | Clin Cancer Res 13(5):1367-73 (2007) |
| 19 | 2004 | Recent advances in cell biology, diagnosis, and therapy of gastrointestinal stromal tumor (GIST). | 
| + | - | nl | Cancer Biol Ther 3(3):251-8 (2004) |
| 20 | 2003 | Gastrointestinal stromal tumors (GIST): C-kit mutations, CD117 expression, differential diagnosis and targeted cancer therapy with Imatinib. | 
| + | - | nl | Pathol Oncol Res 9(1):13-9 (2003) |
| 21 | 2009 | Gastrointestinal stromal tumors: a 19 year experience. | 
| + | - | nl | Isr Med Assoc J 11(2):98-102 (2009) |
| 22 | 2007 | Ménétrier disease and gastrointestinal stromal tumors: hyperproliferative disorders of the stomach. | 
| + | - | nl | J Clin Invest 117(1):70-80 (2007) |
| 23 | 2006 | An update on molecular genetics of gastrointestinal stromal tumours. | 
| + | - | nl | J Clin Pathol 59(6):557-63 (2006) |
| 24 | 2009 | Current standards and progress in understanding and treatment of GIST. | 
| + | - | nl | Swiss Med Wkly 139(7-8):90-102 (2009) |
| 25 | 2004 | Management of gastrointestinal stromal tumors: from diagnosis to treatment. | 
| + | - | nl | Swiss Med Wkly 134(11-12):145-53 (2004) |
| 26 | 2006 | Gastrointestinal stromal tumor: role of CT in diagnosis and in response evaluation and surveillance after treatment with imatinib. | 
| + | - | nl | Radiographics 26(2):481-95 (2006) |
| 27 | 2003 | Gastrointestinal stromal tumors: radiologic features with pathologic correlation. | 
| + | - | nl | Radiographics 23(2):283-304, 456; quiz 532 (2003) |
| 28 | 2010 | Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. | 
| + | - | nl | Ann Oncol 21 Suppl 5(-):v98-102 (2010) |
| 29 | 2010 | Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib. | 
| + | - | nl | Ann Oncol 21(2):208-15 (2010) |
| 30 | 2009 | Gastrointestinal stromal tumours: ESMO clinical recommendations for diagnosis, treatment and follow-up. | 
| + | - | nl | Ann Oncol 20 Suppl 4(-):64-7 (2009) |
| 31 | 2010 | Molecular basis and management of gastrointestinal stromal tumors. | 
| + | - | nl | World J Gastroenterol 16(22):2726-34 (2010) |
| 32 | 2010 | Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. | 
| + | - | nl | J Clin Endocrinol Metab 95(7):3111-7 (2010) |
| 33 | 2009 | Carney triad: a syndrome featuring paraganglionic, adrenocortical, and possibly other endocrine tumors. | 
| + | - | nl | J Clin Endocrinol Metab 94(10):3656-62 (2009) |
| 34 | 2010 | Approval summary: imatinib mesylate in the adjuvant treatment of malignant gastrointestinal stromal tumors. | 
| + | - | nl | Oncologist 15(3):300-7 (2010) |
| 35 | 2010 | Perspective on updated treatment guidelines for patients with gastrointestinal stromal tumors. | 
| + | - | nl | Cancer 116(22):5126-37 (2010) |
| 36 | 2010 | The role of high-dose imatinib in the management of patients with gastrointestinal stromal tumor. | 
| + | - | nl | Cancer 116(8):1847-58 (2010) |
| 37 | 2007 | A histopathological review of gastrointestinal related mesenchymal tumors: the hidden GIST. | 
| + | - | nl | Isr Med Assoc J 9(11):810-2 (2007) |
| 38 | 2011 | Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation. | 
| + | - | nl | Health Technol Assess 15(25):1-178 (2011) |
| 39 | 2010 | Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours. | 
| + | - | nl | Health Technol Assess 14(Suppl. 2):63-70 (2010) |
| 40 | 2006 | Gastrointestinal stromal tumors (GIST). | 
| + | - | nl | Gastroenterol Clin Biol 30 Spec No 2(-):2S98-2S101 (2006) |
| 41 | 2005 | The radiology of gastrointestinal stromal tumours (GIST). | 
| + | - | nl | Cancer Imaging 5(-):150-6 (2005) |